COMP <GO>
GEV vs EMR // EV/EBITDA & P/E VALUATION
GE Vernova Inc. (NYSE) VS. Emerson Electric Company (NYSE) • 15-METRIC TALLY: GEV 3
— EMR 11
▲ EV/EBITDA & P/E VALUATION LEADER: EMR
LAST: $887.85 (+1.12%) • MKT CAP: $234.99B
valuation
87.5x
LAST: $170.74 (+1.81%) • MKT CAP: $95.24B
valuation
30.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GEV VS. EMR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GEV | EMR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.80% | 52.80% | -33.00 | EMR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.40% | 9.70% | -5.30 | EMR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 87.5x | 30.9x | +56.60 | EMR | /valuation <GO> |
| Free Cash Flow Yield | 1.39% | 2.80% | -1.41 | EMR | /fcf-yield <GO> |
| Operating Margin | 3.60% | 15.50% | -11.90 | EMR | /operating-margins <GO> |
| Net Profit Margin | 12.80% | 12.70% | +0.10 | GEV | /net-margins <GO> |
| Revenue Growth (YoY) | 9.00% | 3.00% | +6.00 | GEV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.12% | 1.25% | -1.13 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.58 | 4.80 | -1.22 | EMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | EMR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.8 | 64.1 | -18.30 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.32 | 1.34 | -0.02 | EMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 44.7x | 38.6x | +6.10 | EMR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $234.99B | $95.24B | $139.75B | GEV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GEV REV | EMR REV | GEV GROSS % | EMR GROSS % | GEV FCF | EMR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.07B | $18.02B | 19.8% | 52.8% | $3.27B | $2.67B |
| FY 2024 | $34.94B | $17.49B | 17.4% | 50.8% | $1.01B | $2.91B |
| FY 2023 | $33.24B | $15.16B | — | — | -$309.8M | -$45.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GEV // BETA 1.32
EMR // BETA 1.34